Nanoparticle cancer vaccines:Design considerations and recent advances

被引:1
作者
Jingjing Liu [1 ]
Lei Miao [2 ]
Jiying Sui [3 ]
Yanyun Hao [1 ]
Guihua Huang [1 ]
机构
[1] The School of Pharmaceutical Sciences, Shandong University
[2] David H.Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
[3] Affiliated Hospital of Shandong Academy of Medical Sciences
关键词
D O I
暂无
中图分类号
R392-3 [研究方法];
学科分类号
100102 ;
摘要
Vaccines therapeutics manipulate host’s immune system and have broad potential for cancer prevention and treatment. However, due to poor immunogenicity and limited safety, fewer cancer vaccines have been successful in clinical trials. Over the past decades, nanotechnology has been exploited to deliver cancer vaccines, eliciting longlasting and effective immune responses. Compared to traditional vaccines, cancer vaccines delivered by nanomaterials can be tuned towards desired immune profiles by(1) optimizing the physicochemical properties of the nanomaterial carriers,(2) modifying the nanomaterials with targeting molecules, or(3) co-encapsulating with immunostimulators. In order to develop vaccines with desired immunogenicity, a thorough understanding of parameters that affect immune responses is required. Herein, we discussed the effects of physicochemical properties on antigen presentation and immune response, including but not limited to size, particle rigidity, intrinsic immunogenicity. Furthermore, we provided a detailed overview of recent preclinical and clinical advances in nanotechnology for cancer vaccines, and considerations for future directions in advancing the vaccine platform to widespread anti-cancer applications.
引用
收藏
页码:576 / 590
页数:15
相关论文
共 76 条
  • [1] Future perspectives in melanoma research “Melanoma Bridge”, Napoli, November 30th–3rd December 2016[J] . Paolo A. Ascierto,Sanjiv S. Agarwala,Gennaro Ciliberto,Sandra Demaria,Reinhard Dummer,Connie P. M. Duong,Soldano Ferrone,Silvia C. Formenti,Claus Garbe,Ruth Halaban,Samir Khleif,Jason J. Luke,Lluis M. Mir,Willem W. Overwijk,Michael Postow,Igor Puzanov,Paul Sondel,Janis M. Taube,Per Thor Straten,David F. Stroncek,Jennifer A. Wargo,Hassane Zarour,Magdalena Thurin.Journal of Translational Medici
  • [2] Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge”, Napoli, November 30th 2016[J] . Paolo A. Ascierto,Bruno Daniele,Hans Hammers,Vera Hirsh,Joseph Kim,Lisa Licitra,Rita Nanda,Sandro Pignata.Journal of Translational Medicine . 2017 (1)
  • [3] pH-sensitive polymer-modified liposome-based immunity-inducing system: Effects of inclusion of cationic lipid and CpG-DNA[J] . Yuta Yoshizaki,Eiji Yuba,Naoki Sakaguchi,Kazunori Koiwai,Atsushi Harada,Kenji Kono.Biomaterials . 2017
  • [4] DNA vaccines for prostate cancer[J] . Christopher D. Zahm,Viswa Teja Colluru,Douglas G. McNeel.Pharmacology and Therapeutics . 2017
  • [5] Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses[J] . Sukmo Kang,Sukyung Ahn,Jeewon Lee,Jin Yong Kim,Minsuk Choi,Vipul Gujrati,Hyungjun Kim,Jinjoo Kim,Eui-Cheol Shin,Sangyong Jon.Journal of Controlled Release . 2017
  • [6] DNA-Loaded Cationic Liposomes Efficiently Function as a Vaccine against Malarial Proteins[J] . Wesley L. Fotoran,Rachele Santangelo,Beatriz N.M. de Miranda,Darrell J. Irvine,Gerhard Wunderlich.Molecular Therapy - Methods & Clinical Developmen . 2017
  • [7] Potential applications of nanoparticles in cancer immunotherapy
    Jia, Yimei
    Omri, Abdelwahab
    Krishnan, Lakshmi
    McCluskie, Michael J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (01) : 63 - 74
  • [8] Albumin nanostructures as advanced drug delivery systems
    Karimi, Mahdi
    Bahrami, Sajad
    Ravari, Soodeh Baghaee
    Zangabad, Parham Sahandi
    Mirshekari, Hamed
    Bozorgomid, Mahnaz
    Shahreza, Somayeh
    Sori, Masume
    Hamblin, Michael R.
    [J]. EXPERT OPINION ON DRUG DELIVERY, 2016, 13 (11) : 1609 - 1623
  • [9] Multifunctional particle-constituted microneedle arrays as cutaneous or mucosal vaccine adjuvant-delivery systems
    Wang, Xueting
    Wang, Ning
    Li, Ning
    Zhen, Yuanyuan
    Wang, Ting
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (08) : 2075 - 2089
  • [10] Dendritic cell maturation and cross‐presentation: timing matters![J] . Andrés Alloatti,Fiorella Kotsias,Joao Gamelas Magalhaes,Sebastian Amigorena.Immunological Reviews . 2016 (1)